Reality CheckJoseph Weber
DRUG-COMPANY BASHERS SAY pharmaceutical companies are gouging a vulnerable public. Ranging from the White House to Congress, they compare wholesale drug prices (up 3.1% last year) with producer prices (up just 0.2%). Senator David Pryor (D-Ark.), a veteran industry critic, figures that means drug inflation was running at 15.5 times the true inflation rate. The message is we need "meaningful restraints" (read: price controls) on drugs.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.